Skip to content

The Effect of Huel on Markers of Inflammation

The Effect of Huel on Markers of Inflammation

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07049874
Enrollment
30
Registered
2025-07-03
Start date
2025-02-01
Completion date
2025-08-01
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

4 Weeks Supplementation of Huel Ready to Eat Foods

Keywords

protein, plant based, Plant protein, inflammation

Brief summary

This project will assess the effect of Huel on markers of gastrointestinal inflammation of 30 generally healthy individuals. The aim is to identify any changes in the markers of inflammation status of volunteers in any of the 9 markers to be monitored. Inflammation status will be measured at the start of the study, after one week of their habitual diets and again after four weeks of consuming two ready to drink Huel products per day, one Hot & Savoury Huel (grain-based option only) and the remainder of their calorie intake to be made up of Huel Powder (v3.1).

Interventions

DIETARY_SUPPLEMENTHuel

Ready to eat huel foods. Containing 2 ready to drink shakes, one savoury meal pack and meal replacement powder. Consumption amounts were based on energy needs of each person

Sponsors

Aelius Biotech
CollaboratorUNKNOWN
Newcastle University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

This is an open label study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Generally healthy Aged 18 years and over Non-pregnant, Non-lactating non-smoking

Exclusion criteria

Smoker Pregnant Lactating BMI \>30 Food allergy Disordered eating Disorder which could impact the study outcomes Medications which could impact the study outcomes

Design outcomes

Primary

MeasureTime frame
C-Reactive proteinbaseline and after 4 weeks supplementation
neutrophilsbaseline and after 4 weeks supplementation
TNF-alphabaseline and after 4 weeks supplementation
IL-10baseline and after 4 weeks supplementation
IL-6baseline and after 4 weeks supplementation

Secondary

MeasureTime frame
Body massbaseline and after 4 weeks supplementation
Body Mass Indexbaseline and after 4 weeks supplementation
Waist cercumferencebaseline and after 4 weeks supplementation
linoleic acidbaseline and after 4 weeks supplementation
arachidonic acidbaseline and after 4 weeks supplementation
alpha-linoleic acidbaseline and after 4 weeks supplementation
eicosapentaenoic acidbaseline and after 4 weeks supplementation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026